Share
In 2014, we began charting a course for the next stage of Acorda’s growth, seeking to identify and acquire promising late-stage therapeutic candidates outside the company to bolster our internal development activities.
...read more
In 2014, we began charting a course for the next stage of Acorda’s growth, seeking to identify and acquire promising late-stage therapeutic candidates outside the company to bolster our internal development activities. These actions were important to accelerate the pursuit of our mission while improving the opportunity to generate long-term value for our shareholders.